Sycomore Asset Management
- SEC CIK
- 0001728681
- Latest filing
- Jul 16, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Sycomore Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −478−100.0% | Sold out | Holders |
| Q2 2023 | 478 | $43.0K | <0.1% | −60−11.2% | Reduced | Holders |
| Q1 2023 | 538 | $44.0K | <0.1% | −406−43.0% | Reduced | Holders |
| Q4 2022 | 944 | $70.0K | <0.1% | +140+17.4% | Added | Holders |
| Q3 2022 | 804 | $67.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 804 | $76.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 804 | $94.0K | <0.1% | +304+60.8% | Added | Holders |
| Q4 2021 | 500 | $65.0K | <0.1% | +500 | New | Holders |